Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.71B | 1.37B | 1.12B | 859.59M | 699.61M | Gross Profit |
1.57B | 989.43M | 810.40M | 616.76M | 500.37M | EBIT |
255.47M | 83.46M | 36.25M | 66.90M | 30.74M | EBITDA |
510.98M | 183.23M | 220.83M | 189.50M | 153.37M | Net Income Common Stockholders |
160.21M | -110.93M | ― | 19.69M | ― |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.53B | 1.12B | 937.17M | 1.11B | 532.32M | Total Assets |
2.95B | 2.49B | 2.35B | 2.02B | 1.15B | Total Debt |
1.22B | 1.15B | 1.02B | 948.60M | 493.73M | Net Debt |
725.33M | 914.23M | 617.60M | 292.56M | 386.46M | Total Liabilities |
1.56B | 1.44B | 1.31B | 1.27B | 726.19M | Stockholders Equity |
1.39B | 1.06B | 1.04B | 743.90M | 419.40M |
Cash Flow | Free Cash Flow | |||
346.54M | 102.22M | ― | 57.90M | 27.06M | Operating Cash Flow |
597.47M | 381.52M | 240.83M | 221.42M | 162.31M | Investing Cash Flow |
-244.34M | -297.92M | -438.16M | -200.49M | -135.91M | Financing Cash Flow |
-94.16M | -296.16M | -62.68M | 551.39M | -50.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | AU$34.09B | 135.25 | 14.13% | 0.20% | -1.78% | 12.79% | |
74 Outperform | AU$13.80B | 53.75 | 8.51% | 2.23% | 17.01% | -26.92% | |
71 Outperform | $26.78B | 132.71 | 13.71% | ― | 23.95% | ― | |
70 Outperform | AU$10.57B | 89.10 | 34.02% | 0.75% | 17.97% | 14.29% | |
62 Neutral | $32.21B | 52.19 | 37.91% | 0.89% | 20.28% | 118.95% | |
60 Neutral | $11.60B | 10.64 | -6.04% | 2.94% | 7.87% | -11.74% | |
43 Neutral | $7.68B | 1,185.16 | 1.71% | 1.91% | -14.38% | -92.03% |
Xero Limited has announced the application for the quotation of 497,878 ordinary fully paid securities on the Australian Securities Exchange (ASX), with an issue date of March 31, 2025. This move is part of the company’s strategy to enhance its financial flexibility and potentially expand its market presence, reflecting a positive outlook for stakeholders and aligning with its growth objectives.
Xero Limited has announced a change in the address of its Sydney registry office, effective from 14 April 2025. The office will relocate to Liberty Place, Level 41, 161 Castlereagh St, Sydney NSW 2000, while telephone numbers and postal addresses remain the same. This change is part of the company’s operational updates and is authorized by the Company Secretary.
Xero Limited announced the cessation of 8,402 restricted stock units due to the lapse of conditional rights, as the conditions for these securities were not met or became incapable of being satisfied. This announcement may impact the company’s issued capital and reflects a strategic adjustment in its securities management.
Xero Limited announced the quotation of additional ordinary fully paid securities on the Australian Securities Exchange (ASX), with a total of 15,057 new securities issued on various dates in February and March 2025. This move reflects Xero’s ongoing efforts to strengthen its market presence and provide value to its stakeholders by expanding its capital base.
Xero Limited has announced a new application for the quotation of its securities on the ASX. The company will have 27,678 newly quoted ordinary fully paid securities, issued following the exercise of options or conversion of other convertible securities. This move is part of Xero’s broader strategy to enhance its market presence and operational capabilities, potentially strengthening its position in the industry and offering benefits to its stakeholders.
Xero Limited has announced its key financial dates for FY26, ending on March 31, 2026. These dates include the board director nominations deadline on July 3, 2025, the annual meeting on August 21, 2025, and the release of half and full-year results on November 13, 2025, and May 14, 2026, respectively. This schedule provides stakeholders with a clear timeline for Xero’s financial reporting, reinforcing its commitment to transparency and strategic planning.
Xero Limited has appointed Claire Bramley as its new Chief Financial Officer, effective April 1, 2025. Bramley, who has a robust background in global finance and technology, previously served as CFO at Teradata and held leadership roles at HP Inc. Her appointment is expected to strengthen Xero’s executive team as they pursue their FY25-27 strategy. Xero’s CEO expressed confidence in Bramley’s ability to drive the company’s growth, given her expertise in financial transformation and her passion for purpose-driven leadership.
Xero Limited has announced the application for quotation of several batches of its fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of ongoing financial strategies, potentially affecting the company’s market presence and investor relations by increasing its stock liquidity and accessibility.